Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3010349 | 0.91 | ALDH1A1 (0.33) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL899908 | 0.88 | MEN1 (0.31) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL1171110 | 0.87 | TSHR (0.38) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL1304385 | 0.87 | TSHR (0.38) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL1170980 | 0.87 | TSHR (0.38) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL27951431 | 0.86 | MEN1 (0.30) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| Pivalate SCHEMBL29249466 | 0.85 | TSHR (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Pivalate SCHEMBL27669731 | 0.85 | TSHR (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL30574288 | 0.84 | ENPEP (0.37) | CYP1A2 | |
| Bicarbonate SCHEMBL8777797 | 0.82 | FFAR3 (0.37) | ALDH1A1TSHRHIF1AMEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170343037-A1 | Reclosable Adhesive Strip | HENKEL AG & CO. KGAA (DE) | 2017-11-30 | — | — | US | claimed |
| EP-3227397-A2 | A RECLOSABLE ADHESIVE STRIP | Henkel AG & Co. KGaA (DE) | 2017-10-11 | — | — | EP | claimed |
| WO-2016087608-A2 | A RECLOSABLE ADHESIVE STRIP | HENKEL AG & CO. KGAA (DE) | 2016-06-09 | — | — | WO | claimed |
| EP-1478668-B1 | THIOL COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPOSITION AND PHOTOSENSITIVE COMPOSITION | SHOWA DENKO KK (JP) | 2013-04-10 | — | — | EP | claimed |
| US-20050153231-A1 | Thiol compound, photopolymerization initiator composition and photosensitive composition | SHOWA DENKO K.K. (JP) | 2005-07-14 | — | — | US | claimed |
| CN-122095275-A | Method for manufacturing wavelength conversion sheet | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122070502-A | Wavelength conversion sheet, and backlight and liquid crystal display device using same | 大日本印刷株式会社 | 2026-05-19 | — | — | CN | disclosed |
| US-12624279-B2 | Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4703778-A1 | WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE | Dai Nippon Printing Co., Ltd. (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-12565548-B2 | Compound, polymerizable composition, and cured product | FUJIFILM CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-4202505-B1 | BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE IN WHICH SAME IS USED, AS WELL AS METHOD FOR SELECTING BARRIER FILM | DAINIPPON PRINTING CO LTD (JP) | 2026-02-18 | — | — | EP | disclosed |
| EP-4201667-B1 | BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACK LIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE WHICH USE SAME | DAINIPPON PRINTING CO LTD (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-7341828-B2 | Thiol compound, photopolymerization initiator composition and photosensitive composition | SHOWA DENKO K.K. (JP) | 2008-03-11 | — | — | US | disclosed |
| US-20070021571-A1 | Curable polymer compound | SHOWA DENKO K.K. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20060079593-A1 | Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same | SHOWA DENKO K.K. (JP) | 2006-04-13 | — | — | US | disclosed |
| US-20060041053-A1 | Color filter black matrix resist composition and carbon black dispersion composition used for the composition | SHOWA DENKO K.K. (JP) | 2006-02-23 | — | — | US | disclosed |
| US-20060036023-A1 | Color filter black matrix resist composition | SHOWA DENKO K.K. (JP) | 2006-02-16 | — | — | US | disclosed |
| US-20050153231-A1 | Thiol compound, photopolymerization initiator composition and photosensitive composition | SHOWA DENKO K.K. (JP) | 2005-07-14 | — | — | US | disclosed |
| EP-1478668-A2 | THIOL COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPOSITION AND PHOTOSENSITIVE COMPOSITION | Showa Denko K.K. (JP) | 2004-11-24 | — | — | EP | disclosed |
| WO-2003072614-A2 | THIOL COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPOSITION AND PHOTOSENSITIVE COMPOSITION | SHOWA DENKO K.K. (JP) | 2003-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624279-B2 | Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device | NLRP1, NLRP3, ALAD | ALDH1A1 45/4885TSHR 2197/4885CYP2D6 2719/4885 |
| US-12565548-B2 | Compound, polymerizable composition, and cured product | SEM1, PSMA1, RER1 | ALDH1A1 1138/4885TSHR 4589/4885CYP2D6 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.